Cell-Free DNA Guided Targeted Therapy Leads To Better Survival In Advanced Non-Small Cell Lung Cancer
SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced a presentation by Memorial Sloan Kettering Cancer Center (MSK) at the upcoming annual meeting of the American Society of Clinical…